NEWARK, Del, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The global peripheral vascular devices market is projected to grow significantly over the next decade, reaching a valuation of USD 8.9 billion by 2032, up from USD 4.7 billion in 2022. This expansion reflects a compound annual growth rate (CAGR) of 6.6%, according to a recent study by Future Market Insights (FMI).
Peripheral vascular stents, a key segment in the market, commanded a 78.5% market share in 2021. These devices are increasingly essential in treating peripheral arterial disease (PAD), which occurs when plaque builds up in the arteries that supply blood to the limbs and body. PAD is closely associated with systemic atherosclerosis, posing a heightened risk of cardiovascular events.
Understanding the Peripheral Vascular Devices Market:
The Peripheral Vascular Devices Market is experiencing significant growth due to the increasing prevalence of vascular diseases, advancements in minimally invasive procedures, and a growing aging population. Peripheral vascular diseases, such as peripheral artery disease (PAD), often lead to blockages in blood vessels outside the heart and brain, and the rising incidence of such conditions is driving demand for peripheral vascular devices. These devices play a crucial role in diagnosing and treating vascular issues, enhancing patient outcomes.
Technological innovations in stents, angioplasty balloons, and atherectomy devices are further propelling market growth. The development of drug-coated balloons and bioresorbable stents has improved the success rates of vascular procedures and reduced the need for repeat interventions. Additionally, the shift toward outpatient procedures and home-based care settings for vascular treatments has broadened the market potential for these devices.
However, the market faces challenges such as the high cost of devices and stringent regulatory requirements, which may limit growth. Nonetheless, emerging economies present significant opportunities for market expansion, driven by improving healthcare infrastructure and increasing awareness about vascular disease treatment options.
Key Takeaways from Market Study
- The Peripheral Vascular Devices Market is expected to grow at a CAGR of 6.6% from 2024 to 2034.
- Market size is projected to rise from USD 4.7 billion in 2022 to USD 8.9 billion by 2032.
- Rising demand for minimally invasive procedures is a key driver of market growth.
- Technological advancements in stents, balloons, and catheters are contributing to increased adoption.
- Emerging economies present significant growth opportunities due to expanding healthcare infrastructure.
“The rising global burden of vascular diseases and technological advancements in treatment options are the key drivers propelling the Peripheral Vascular Devices Market. With a focus on minimally invasive procedures and better patient outcomes, the market is expected to see sustained growth, particularly in emerging regions where healthcare infrastructure is rapidly improving.” Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Drivers and Opportunities
The primary driver of the Peripheral Vascular Devices Market is the increasing incidence of peripheral artery disease and other vascular conditions due to rising obesity rates, diabetes, and an aging population. These factors are leading to a higher demand for advanced medical devices that can provide effective and minimally invasive treatment options.
Opportunities in the market are abundant, with manufacturers investing in the development of next-generation vascular devices that offer improved patient outcomes and reduced procedure times. Drug-eluting stents, bioresorbable vascular scaffolds, and catheter-based technologies are some innovations driving the market forward. Additionally, the adoption of telemedicine and home-based healthcare services is expected to open new avenues for peripheral vascular device applications.
Component Insights
Peripheral vascular devices consist of a wide range of products, including angioplasty balloons, stents, catheters, guidewires, and atherectomy devices. The stent segment holds the largest market share, driven by the increasing use of drug-eluting and bioresorbable stents. These stents have significantly improved patient outcomes by reducing restenosis rates and the need for repeat procedures.
Angioplasty balloons are also a major component, with drug-coated balloons gaining popularity due to their effectiveness in preventing restenosis. Atherectomy devices, used to remove plaque from blood vessels, are seeing increased adoption in complex cases where standard angioplasty procedures may not be effective.
Market's Prime Determinants of Growth, Trends, and Opportunities
The Peripheral Vascular Devices Market is primarily driven by the increasing incidence of peripheral vascular diseases, coupled with the rising demand for minimally invasive surgical procedures. As the global population ages and lifestyle diseases such as diabetes and obesity become more prevalent, the need for effective vascular treatment options has grown significantly.
A key trend shaping the market is the growing preference for drug-coated balloons and bioresorbable stents, which offer superior long-term results and reduce the need for repeat interventions. Another emerging trend is the shift toward outpatient and home-based care, which has created opportunities for smaller, portable devices that allow for safer, quicker recovery.
Opportunities for market growth are abundant in developing regions where healthcare infrastructure is improving and access to advanced vascular care is expanding. Manufacturers are also focusing on developing cost-effective solutions to meet the growing demand in these markets.
Growth Drivers
- Increasing Prevalence of Vascular Diseases: The rising incidence of peripheral artery disease (PAD) and related conditions is fueling the demand for peripheral vascular devices.
- Technological Advancements: Innovations in stents, angioplasty balloons, and atherectomy devices are improving procedural success rates and patient outcomes, driving market growth.
- Minimally Invasive Procedures: Growing demand for minimally invasive surgical options, which reduce recovery time and complications, is contributing to the widespread adoption of peripheral vascular devices.
Emerging Markets: Rapidly developing healthcare infrastructure in regions such as Asia-Pacific, Latin America, and the Middle East & Africa offers significant growth potential for market players.
Competitive Landscape
The global peripheral vascular devices market is highly fragmented, with numerous companies vying for market share. Leading players are adopting strategies such as mergers and acquisitions, partnerships, collaborations, and product innovations to cater to the growing demand and expand their customer reach.
In January 2022, Cook Medical received FDA Breakthrough Device designation for a new drug-eluting stent designed for below-the-knee (BTK) applications. This innovative stent aims to treat patients suffering from chronic limb-threatening ischemia (CLTI).
In another significant development, Cordis, a subsidiary of Cardinal Health, secured new group purchasing agreements with Premier on June 10, 2019, covering eight categories of interventional products. These agreements, which include Vascular Closure Devices (VCD), became effective on June 1st, while the coronary agreements were implemented starting July 1st.
Future Market Insights continues to track the latest advancements and strategic moves by companies in the peripheral vascular devices industry, with further insights available in the full report.
Key Companies Profiled:
- Abbott Laboratories;
- Boston Scientific Corporation;
- Cook Medical Inc.;
- MicroPort Scientific Corporation (Endovastec™);
- Medtronic Plc.;
- Cardinal Health, Inc.;
- B. Braun Melsungen AG;
- BIOTRONIK SE & Co. KG;
- Becton, Dickinson, and Company;
- W. L. Gore & Associates Inc.;
- Getinge AB; Terumo Corp;
- Kyoto Medical Planning Co Ltd;
- iVascular S.L.U;
- AMG International GmbH;
- ENDOCOR GmbH;
- Meril Life Sciences Pvt. Ltd.;
- Nano Therapeutics Pvt Ltd;
- Koninklijke Philips N.V.;
- REVA Medical
To Gain In-Depth Insights on Market, Browse Complete Report:
https://www.futuremarketinsights.com/reports/peripheral-vascular-devices-market
Key Market Segments Covered in Peripheral Vascular Devices Industry Research:
By Product:
- Peripheral Vascular Stents
- Self-Expanding Stents
- Balloon Expanding Stents
- Covered Stents
- Drug-Eluting Stents
- Drug Eluting Balloons
- Peripheral Vascular Bioresorbable Scaffolds
By Indication:
- Target Artery Instability (TAI)
- Access Artery Injury (AAI)
- Peripheral Arterial Disease
- Arteriovenous Fistulas
- Peripheral Aneurysms
- Others
By Artery:
- Carotid Artery
- Fem-Pop Artery
- lliac Artery
- Infrapop Artery
By End User:
- Hospitals
- Ambulatory Surgical Centers/Outpatients
- Cardiac Catheterization Labs
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
German Translation
Der globale Markt für periphere Gefäßgeräte dürfte im Laufe des nächsten Jahrzehnts deutlich wachsen und von 4,7 Milliarden USD im Jahr 2022 auf 8,9 Milliarden USD im Jahr 2032 wachsen . Dieser Zuwachs entspricht einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 6,6 % gemäß einer aktuellen Studie von Future Market Insights (FMI).
Periphere Gefäßstents, ein Schlüsselsegment des Marktes, hatten 2021 einen Marktanteil von 78,5 %. Diese Geräte sind zunehmend unverzichtbar bei der Behandlung der peripheren arteriellen Verschlusskrankheit (pAVK) , die auftritt, wenn sich Plaque in den Arterien ansammelt, die die Gliedmaßen und den Körper mit Blut versorgen. PAVK ist eng mit systemischer Arteriosklerose verbunden und birgt ein erhöhtes Risiko für kardiovaskuläre Ereignisse.
Den Markt für periphere Gefäßgeräte verstehen :
Der Markt für periphere Gefäßgeräte verzeichnet aufgrund der zunehmenden Verbreitung von Gefäßerkrankungen, der Fortschritte bei minimalinvasiven Verfahren und einer wachsenden alternden Bevölkerung ein erhebliches Wachstum. Periphere Gefäßerkrankungen wie die periphere arterielle Verschlusskrankheit (pAVK) führen häufig zu Verstopfungen der Blutgefäße außerhalb des Herzens und des Gehirns, und die steigende Inzidenz solcher Erkrankungen treibt die Nachfrage nach peripheren Gefäßgeräten an. Diese Geräte spielen eine entscheidende Rolle bei der Diagnose und Behandlung von Gefäßproblemen und verbessern die Patientenergebnisse.
Technologische Innovationen bei Stents, Angioplastieballons und Atherektomiegeräten treiben das Marktwachstum weiter voran. Die Entwicklung von medikamentenbeschichteten Ballons und bioresorbierbaren Stents hat die Erfolgsraten bei Gefäßoperationen verbessert und die Notwendigkeit wiederholter Eingriffe reduziert. Darüber hinaus hat der Trend zu ambulanten Eingriffen und häuslicher Pflege bei Gefäßbehandlungen das Marktpotenzial für diese Geräte erweitert.
Der Markt steht jedoch vor Herausforderungen wie den hohen Kosten der Geräte und strengen gesetzlichen Anforderungen, die das Wachstum einschränken könnten. Dennoch bieten Schwellenländer erhebliche Möglichkeiten zur Markterweiterung, die durch eine Verbesserung der Gesundheitsinfrastruktur und ein zunehmendes Bewusstsein für Behandlungsmöglichkeiten bei Gefäßerkrankungen vorangetrieben werden.
Wichtige Erkenntnisse aus der Marktstudie
- Der Markt für periphere Gefäßgeräte soll von 2024 bis 2034 mit einer durchschnittlichen jährlichen Wachstumsrate von 6,6 % wachsen.
- Die Marktgröße soll von 4,7 Milliarden US-Dollar im Jahr 2022 auf 8,9 Milliarden US-Dollar im Jahr 2032 steigen .
- Die steigende Nachfrage nach minimalinvasiven Eingriffen ist ein wichtiger Treiber des Marktwachstums.
- Technologische Fortschritte bei Stents, Ballons und Kathetern tragen zu einer zunehmenden Akzeptanz bei.
- Aufgrund der wachsenden Gesundheitsinfrastruktur bieten Schwellenländer erhebliche Wachstumschancen.
„Die weltweit steigende Belastung durch Gefäßerkrankungen und der technologische Fortschritt bei den Behandlungsmöglichkeiten sind die Haupttreiber für den Markt für periphere Gefäßgeräte. Mit einem Schwerpunkt auf minimalinvasiven Verfahren und besseren Patientenergebnissen wird erwartet, dass der Markt ein nachhaltiges Wachstum verzeichnet, insbesondere in Schwellenregionen, in denen sich die Gesundheitsinfrastruktur rasch verbessert“, sagt Sabyasachi Ghosh (Associate Vice President bei Future Market Insights, Inc.).
Treiber und Chancen
Der Haupttreiber des Marktes für periphere Gefäßgeräte ist die zunehmende Inzidenz peripherer arterieller Verschlusskrankheiten und anderer Gefäßerkrankungen aufgrund steigender Fettleibigkeitsraten, Diabetes und einer alternden Bevölkerung. Diese Faktoren führen zu einer höheren Nachfrage nach fortschrittlichen medizinischen Geräten, die wirksame und minimalinvasive Behandlungsmöglichkeiten bieten können.
Der Markt bietet zahlreiche Chancen. Hersteller investieren in die Entwicklung von Gefäßgeräten der nächsten Generation, die bessere Behandlungsergebnisse für Patienten und kürzere Behandlungszeiten bieten. Medikamentenfreisetzende Stents, bioresorbierbare Gefäßgerüste und katheterbasierte Technologien sind einige Innovationen, die den Markt vorantreiben. Darüber hinaus dürfte die Einführung von Telemedizin und häuslichen Gesundheitsdiensten neue Möglichkeiten für die Anwendung peripherer Gefäßgeräte eröffnen.
Einblicke in Komponenten
Periphere Gefäßgeräte umfassen eine breite Produktpalette, darunter Angioplastieballons, Stents, Katheter, Führungsdrähte und Atherektomiegeräte. Das Stentsegment hält den größten Marktanteil, was auf die zunehmende Verwendung von medikamentenfreisetzenden und bioresorbierbaren Stents zurückzuführen ist. Diese Stents haben die Behandlungsergebnisse der Patienten deutlich verbessert, indem sie die Restenoserate und die Notwendigkeit wiederholter Eingriffe verringern.
Auch Angioplastieballons sind ein wichtiger Bestandteil. Arzneimittelbeschichtete Ballons werden immer beliebter, da sie Restenosen wirksam vorbeugen. Atherektomiegeräte, die zur Entfernung von Plaque aus Blutgefäßen verwendet werden, werden zunehmend in komplexen Fällen eingesetzt, in denen Standardverfahren der Angioplastie möglicherweise nicht wirksam sind.
Die wichtigsten Marktfaktoren für Wachstum, Trends und Chancen
Der Markt für periphere Gefäßgeräte wird vor allem durch die zunehmende Anzahl peripherer Gefäßerkrankungen sowie die steigende Nachfrage nach minimalinvasiven chirurgischen Eingriffen angetrieben. Da die Weltbevölkerung altert und Zivilisationskrankheiten wie Diabetes und Fettleibigkeit immer häufiger auftreten, ist der Bedarf an effektiven Gefäßbehandlungsmöglichkeiten deutlich gestiegen.
Ein wichtiger Trend, der den Markt prägt, ist die zunehmende Vorliebe für medikamentenbeschichtete Ballons und bioresorbierbare Stents, die bessere Langzeitergebnisse bieten und die Notwendigkeit wiederholter Eingriffe verringern. Ein weiterer aufkommender Trend ist die Verlagerung hin zu ambulanter und häuslicher Pflege, was Möglichkeiten für kleinere, tragbare Geräte geschaffen hat, die eine sicherere und schnellere Genesung ermöglichen.
Opportunities for market growth are abundant in developing regions where healthcare infrastructure is improving and access to advanced vascular care is expanding. Manufacturers are also focusing on developing cost-effective solutions to meet the growing demand in these markets.
Growth Drivers
- Increasing Prevalence of Vascular Diseases: The rising incidence of peripheral artery disease (PAD) and related conditions is fueling the demand for peripheral vascular devices.
- Technological Advancements: Innovations in stents, angioplasty balloons, and atherectomy devices are improving procedural success rates and patient outcomes, driving market growth.
- Minimally Invasive Procedures: Growing demand for minimally invasive surgical options, which reduce recovery time and complications, is contributing to the widespread adoption of peripheral vascular devices.
Emerging Markets: Rapidly developing healthcare infrastructure in regions such as Asia-Pacific, Latin America, and the Middle East & Africa offers significant growth potential for market players.
Competitive Landscape
The global peripheral vascular devices market is highly fragmented, with numerous companies vying for market share. Leading players are adopting strategies such as mergers and acquisitions, partnerships, collaborations, and product innovations to cater to the growing demand and expand their customer reach.
In January 2022, Cook Medical received FDA Breakthrough Device designation for a new drug-eluting stent designed for below-the-knee (BTK) applications. This innovative stent aims to treat patients suffering from chronic limb-threatening ischemia (CLTI).
In another significant development, Cordis, a subsidiary of Cardinal Health, secured new group purchasing agreements with Premier on June 10, 2019, covering eight categories of interventional products. These agreements, which include Vascular Closure Devices (VCD), became effective on June 1st, while the coronary agreements were implemented starting July 1st.
Future Market Insights continues to track the latest advancements and strategic moves by companies in the peripheral vascular devices industry, with further insights available in the full report.
Key Companies Profiled:
- Abbott Laboratories;
- Boston Scientific Corporation;
- Cook Medical Inc.;
- MicroPort Scientific Corporation (Endovastec™);
- Medtronic Plc.;
- Cardinal Health, Inc.;
- Braun Melsungen AG;
- BIOTRONIK SE & Co. KG;
- Becton, Dickinson, and Company;
- L. Gore & Associates Inc.;
- Getinge AB; Terumo Corp;
- Kyoto Medical Planning Co Ltd;
- iVascular S.L.U;
- AMG International GmbH;
- ENDOCOR GmbH;
- Meril Life Sciences Pvt. Ltd.;
- Nano Therapeutics Pvt Ltd;
- Koninklijke Philips N.V.;
- REVA Medical
Key Market Segments Covered in Peripheral Vascular Devices Industry Research:
By Product:
- Peripheral Vascular Stents
- Self-Expanding Stents
- Balloon Expanding Stents
- Covered Stents
- Drug-Eluting Stents
- Drug Eluting Balloons
- Periphere vaskuläre bioresorbierbare Gerüste
Nach Indikation:
- Zielarterieninstabilität (TAI)
- Verletzung der Zugangsarterie (AAI)
- Periphere arterielle Verschlusskrankheit
- Arteriovenöse Fisteln
- Periphere Aneurysmen
- Sonstiges
Nach Arterie:
- Halsschlagader
- Fem-Pop-Arterie
- Arteria lliace
- Infrapop-Arterie
Nach Endbenutzer:
- Krankenhäuser
- Ambulante chirurgische Zentren/Ambulanzen
- Herzkatheterlabore
Nach Region:
- Nordamerika
- Lateinamerika
- Europa
- Südasien
- Ostasien
- Ozeanien
- Naher Osten und Afrika (MEA)
Author By
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's Extensive Coverage in the Healthcare Domain:
In the recently revised research report made by FMI, the peripheral vascular stent market is expected to record US$ 4,267.70 million in 2024.
The overall valuation of the Peripheral Intravenous Catheter Market is expected to surpass US$ 13,006.1 million by 2034, up from US$ 6,489.3 million in 2024.
The peripheral angioplasty market size is projected to be worth US$ 3.4 billion in 2023. The market is likely to surpass US$ 7.2 billion by 2033 at a CAGR of 7.7% during the forecast period.
The global peripheral micro catheters market is advancing at a CAGR of 7.5% from 2022 to 2032, garnering a worth of around US$ 1872 million by 2032, up from US$ 875 million in 2022.
The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period.
The global demand for pain management devices is expected to grow at a healthy CAGR of 9% between 2022 and 2032,
The global diabetes care devices market size is projected to be valued at US$ 9.7 Bn in 2022 and is anticipated to reach US$ 17.87 Bn by 2032,
The global cardiovascular enterprise viewer market has set a valuation of US$ 44.4 Bn in 2021, and further, is expected to expand at a CAGR of 4.0% to reach US$ 67.8 Bn by the year 2032.
During the projected timeframe, the non-vascular stents market is predicted to increase at a CAGR of 4.5%. (2022 - 2032).
The global cardiovascular needle market was valued at around US$ 85.2 Mn at the end of 2021.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
